These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
766 related articles for article (PubMed ID: 27177441)
1. Systematic review and meta-analysis of randomized clinical trials (RCTs) comparing topical calcineurin inhibitors with topical corticosteroids for atopic dermatitis: A 15-year experience. Broeders JA; Ahmed Ali U; Fischer G J Am Acad Dermatol; 2016 Aug; 75(2):410-419.e3. PubMed ID: 27177441 [TBL] [Abstract][Full Text] [Related]
3. Review of Atopic Dermatitis and Topical Therapies. Mayba JN; Gooderham MJ J Cutan Med Surg; 2017; 21(3):227-236. PubMed ID: 28300440 [TBL] [Abstract][Full Text] [Related]
4. Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis. Siegfried EC; Jaworski JC; Kaiser JD; Hebert AA BMC Pediatr; 2016 Jun; 16():75. PubMed ID: 27267134 [TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis. Frankel HC; Qureshi AA Am J Clin Dermatol; 2012 Apr; 13(2):113-23. PubMed ID: 22263704 [TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis. Breuer K; Werfel T; Kapp A Am J Clin Dermatol; 2005; 6(2):65-77. PubMed ID: 15799678 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials. Schmitt J; von Kobyletzki L; Svensson A; Apfelbacher C Br J Dermatol; 2011 Feb; 164(2):415-28. PubMed ID: 20819086 [TBL] [Abstract][Full Text] [Related]
8. Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas. Draelos ZD Curr Med Res Opin; 2008 Apr; 24(4):985-94. PubMed ID: 18284804 [TBL] [Abstract][Full Text] [Related]
9. Calcineurin inhibitors in pediatric atopic dermatitis: a review of current evidence. Kalavala M; Dohil MA Am J Clin Dermatol; 2011 Feb; 12(1):15-24. PubMed ID: 21067248 [TBL] [Abstract][Full Text] [Related]
10. How Clinically Relevant Are Treatment Comparisons of Topical Calcineurin Inhibitor Trials for Atopic Eczema? Wilkes SR; Nankervis H; Tavernier E; Maruani A; Williams HC J Invest Dermatol; 2016 Oct; 136(10):1944-1949. PubMed ID: 27265005 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials. Ashcroft DM; Dimmock P; Garside R; Stein K; Williams HC BMJ; 2005 Mar; 330(7490):516. PubMed ID: 15731121 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and economics of topical calcineurin inhibitors for the treatment of atopic dermatitis. Abramovits W; Hung P; Tong KB Am J Clin Dermatol; 2006; 7(4):213-22. PubMed ID: 16901181 [TBL] [Abstract][Full Text] [Related]
13. Safety of topical medications in the management of paediatric atopic dermatitis: An updated systematic review. Zhao S; Hwang A; Miller C; Lio P Br J Clin Pharmacol; 2023 Jul; 89(7):2039-2065. PubMed ID: 37075252 [TBL] [Abstract][Full Text] [Related]
14. A Comparison of Topical Corticosteroids and Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis. Pena J; Zameza PA; Pixley JN; Remitz A; Feldman SR J Allergy Clin Immunol Pract; 2023 May; 11(5):1347-1359. PubMed ID: 36997119 [TBL] [Abstract][Full Text] [Related]
15. Corticosteroid therapy in the treatment of pediatric patients with atopic dermatitis. Fröschl B; Arts D; Leopold C GMS Health Technol Assess; 2007 Sep; 3():Doc09. PubMed ID: 21289943 [TBL] [Abstract][Full Text] [Related]
16. A systematic review of tacrolimus ointment compared with corticosteroids in the treatment of atopic dermatitis. Svensson A; Chambers C; Gånemo A; Mitchell SA Curr Med Res Opin; 2011 Jul; 27(7):1395-406. PubMed ID: 21563877 [TBL] [Abstract][Full Text] [Related]
17. Pimecrolimus: a review of its use in atopic dermatitis. Wellington K; Noble S Am J Clin Dermatol; 2004; 5(6):479-95. PubMed ID: 15663345 [TBL] [Abstract][Full Text] [Related]
18. Cancer risk with topical calcineurin inhibitors, pimecrolimus and tacrolimus, for atopic dermatitis: a systematic review and meta-analysis. Devasenapathy N; Chu A; Wong M; Srivastava A; Ceccacci R; Lin C; MacDonald M; Wen A; Steen J; Levine M; Pyne L; Schneider L; Chu DK; Lancet Child Adolesc Health; 2023 Jan; 7(1):13-25. PubMed ID: 36370744 [TBL] [Abstract][Full Text] [Related]
19. Addressing treatment challenges in atopic dermatitis with novel topical therapies. Silverberg JI; Nelson DB; Yosipovitch G J Dermatolog Treat; 2016 Nov; 27(6):568-576. PubMed ID: 27165566 [TBL] [Abstract][Full Text] [Related]
20. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. Beck LA; Thaçi D; Hamilton JD; Graham NM; Bieber T; Rocklin R; Ming JE; Ren H; Kao R; Simpson E; Ardeleanu M; Weinstein SP; Pirozzi G; Guttman-Yassky E; Suárez-Fariñas M; Hager MD; Stahl N; Yancopoulos GD; Radin AR N Engl J Med; 2014 Jul; 371(2):130-9. PubMed ID: 25006719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]